Phase II Study of Cisplatin and Dacarbazine for Metastatic Colorectal Carcinoma Resistant to 5-Fluorouracil

Publisher： Karger

E-ISSN： 1423-0232|56|4|297-300

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.4, 1999-05, pp. : 297-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer

By  

Oncology, Vol. 61, Iss. 1, 2001-07 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

Cisplatin, Raltitrexed, Levofolinic Acid and 5-Fluorouracil in Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Randomized Study

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 232-238

Karger

Access to resources Recommend Favorite

5-Fluorouracil: Synchronous Application of Continuous and Bolus Therapy in Heavily Pretreated Metastatic Colorectal Cancer: A Phase I/II Study

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 128-132

Karger

Access to resources Recommend Favorite

Phase II Study of Cisplatin and 5-Fluorouracil (PF) and Mitomycin C, Vincristine, Cisplatin and 5-Fluorouracil (MVPF) in Patients with Metastatic Large Bowel Cancer: An Eastern Cooperative Oncology Group Study (EST 1285)

By  

Oncology, Vol. 66, Iss. 2, 2004-05 ,pp. : 118-125

Karger

Access to resources Recommend Favorite

A Phase II Study with 5-Fluorouracil, Folinic Acid and Oxaliplatin (FOLFOX-4 Regimen) in Patients with Metastatic Renal Cell Carcinoma

By  

Oncology, Vol. 64, Iss. 1, 2002-12 ,pp. : 25-27

Karger

Access to resources Recommend Favorite